Myriam Herrera-Arevalo
Cali, VAC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
PvGTSeq and PvCRiSP: Two amplicon-based targeted sequencing panels for Plasmodium vivax.
Journal: PLoS neglected tropical diseases
Published: October 18, 2025
Correction: Rojas-Peña et al. Individualized Transcriptional Resolution of Complicated Malaria in a Colombian Study. J. Pers. Med. 2018, 8, 29.
Journal: Journal of personalized medicine
Published: September 17, 2024
Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia.
Journal: Journal of medical virology
Published: May 22, 2024
Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites.
Journal: Scientific reports
Published: October 28, 2023
Genomics of Plasmodium vivax in Colombia reveals evidence of local bottle-necking and inter-country connectivity in the Americas.
Journal: Scientific reports
Published: July 03, 2023
Seroprevalence of viral and bacterial pathogens among malaria patients in an endemic area of southern Venezuela.
Journal: Infectious diseases of poverty
Published: November 04, 2022
A SARS-CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients.
Journal: Frontiers in immunology
Published: February 20, 2022
Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.
Journal: Frontiers in immunology
Published: January 16, 2022
Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c mice.
Journal: Vaccine
Published: June 10, 2021
Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine.
Journal: Nature communications
Published: February 20, 2021
Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems.
Journal: Frontiers in immunology
Published: November 28, 2020
Last Updated: 09/26/2026